Moreover, MDA-7/IL-24 induced potent “bystander antitumor” activity, an ability to block tumor angiogenesis, synergy with radiation, chemotherapy, monoclonal antibody therapies and immune modulatory activity [11], [12], which make it a ideal tool for cancer gene therapy. This evidence concerns the gene IL24 and neoplasm.